EVGN
Price
$1.23
Change
-$0.04 (-3.15%)
Updated
Apr 3, 12:38 PM (EDT)
Capitalization
8.49M
49 days until earnings call
RARE
Price
$35.37
Change
-$0.00 (-0.00%)
Updated
Apr 3, 04:41 PM (EDT)
Capitalization
3.32B
28 days until earnings call
Ad is loading...

EVGN vs RARE

Header iconEVGN vs RARE Comparison
Open Charts EVGN vs RAREBanner chart's image
Evogene
Price$1.23
Change-$0.04 (-3.15%)
Volume$100
Capitalization8.49M
Ultragenyx Pharmaceutical
Price$35.37
Change-$0.00 (-0.00%)
Volume$1.71K
Capitalization3.32B
EVGN vs RARE Comparison Chart
Loading...
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVGN vs. RARE commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVGN is a Hold and RARE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (EVGN: $1.27 vs. RARE: $35.37)
Brand notoriety: EVGN and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVGN: 19% vs. RARE: 80%
Market capitalization -- EVGN: $8.49M vs. RARE: $3.32B
EVGN [@Biotechnology] is valued at $8.49M. RARE’s [@Biotechnology] market capitalization is $3.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVGN’s FA Score shows that 0 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • EVGN’s FA Score: 0 green, 5 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, EVGN is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVGN’s TA Score shows that 4 TA indicator(s) are bullish while RARE’s TA Score has 4 bullish TA indicator(s).

  • EVGN’s TA Score: 4 bullish, 4 bearish.
  • RARE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both EVGN and RARE are a good buy in the short-term.

Price Growth

EVGN (@Biotechnology) experienced а -3.79% price change this week, while RARE (@Biotechnology) price change was -6.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.22%. For the same industry, the average monthly price growth was -10.33%, and the average quarterly price growth was -14.34%.

Reported Earning Dates

EVGN is expected to report earnings on May 22, 2025.

RARE is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-8.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($3.32B) has a higher market cap than EVGN($8.49M). RARE YTD gains are higher at: -15.926 vs. EVGN (-32.086). EVGN has higher annual earnings (EBITDA): -20.4M vs. RARE (-469M). RARE has more cash in the bank: 610M vs. EVGN (20M). EVGN has less debt than RARE: EVGN (11M) vs RARE (40.3M). RARE has higher revenues than EVGN: RARE (560M) vs EVGN (7.48M).
EVGNRAREEVGN / RARE
Capitalization8.49M3.32B0%
EBITDA-20.4M-469M4%
Gain YTD-32.086-15.926201%
P/E Ratio0.30N/A-
Revenue7.48M560M1%
Total Cash20M610M3%
Total Debt11M40.3M27%
FUNDAMENTALS RATINGS
EVGN vs RARE: Fundamental Ratings
EVGN
RARE
OUTLOOK RATING
1..100
1355
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9287
P/E GROWTH RATING
1..100
86100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EVGN's Valuation (43) in the Biotechnology industry is in the same range as RARE (73). This means that EVGN’s stock grew similarly to RARE’s over the last 12 months.

EVGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RARE (100). This means that EVGN’s stock grew similarly to RARE’s over the last 12 months.

EVGN's SMR Rating (100) in the Biotechnology industry is in the same range as RARE (100). This means that EVGN’s stock grew similarly to RARE’s over the last 12 months.

RARE's Price Growth Rating (87) in the Biotechnology industry is in the same range as EVGN (92). This means that RARE’s stock grew similarly to EVGN’s over the last 12 months.

EVGN's P/E Growth Rating (86) in the Biotechnology industry is in the same range as RARE (100). This means that EVGN’s stock grew similarly to RARE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVGNRARE
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 18 days ago
81%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THRD3.550.19
+5.65%
Third Harmonic Bio
WULF2.980.10
+3.47%
TeraWulf
DORM124.752.11
+1.72%
Dorman Products
NICE157.702.61
+1.68%
NICE Ltd
RETO3.50-0.16
-4.32%
ReTo Eco-Solutions Inc

EVGN and

Correlation & Price change

A.I.dvisor tells us that EVGN and AXON have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVGN and AXON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVGN
1D Price
Change %
EVGN100%
+1.60%
AXON - EVGN
30%
Poorly correlated
+3.18%
FATE - EVGN
29%
Poorly correlated
+1.70%
ARRY - EVGN
28%
Poorly correlated
+1.65%
KZR - EVGN
28%
Poorly correlated
+2.00%
RARE - EVGN
27%
Poorly correlated
+4.52%
More